thiazoles has been researched along with gsk 1070916 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertaina, A; Bressanin, D; Cappellini, A; Chiarini, F; Evangelisti, C; Locatelli, F; Lonetti, A; Martelli, AM; McCubrey, JA; Melchionda, F; Pession, A; Spartà , AM | 1 |
1 other study(ies) available for thiazoles and gsk 1070916
Article | Year |
---|---|
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aza Compounds; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Coculture Techniques; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Indoles; Jurkat Cells; Mice; Molecular Targeted Therapy; Polo-Like Kinase 1; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Signal Transduction; Thiazoles; Tumor Cells, Cultured | 2014 |